Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-JSMO: Combinations with immuno-oncology agents for gastrointestinal cancer: Which ones make the best partners?

Combinations with immune-oncology agents for GI cancers: Their scientific rationales

Date

08 Sep 2017

Session

ESMO-JSMO: Combinations with immuno-oncology agents for gastrointestinal cancer: Which ones make the best partners?

Presenters

Kohei Shitara

Authors

K. Shitara

Author affiliations

  • -, National Cancer Center Hospital East, 277-8577 - Kashiwa/JP
More

Resources

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.